More recently a vaccination approach to CLL (using PMA and ionomycin-stimulated CLLs as vaccine) [15] in concert with a blockade using anti-human CD200 antibody was shown to attenuate the local and metastatic spread of CLL cells in a NOD.SCID mouse model (below). Here, CD200 is linked to B-cell chronic lymphocytic leukemia.